Evidence map›Paper›PMID 42188049›Full record

ArticleMetabolites2026

Pyrroloquinoline Quinone Mitigates Type 2 Diabetes-Induced Cardiac Injury Through Mitochondrial Quality Control and Inhibition of NLRP3-Dependent Pyroptosis.

Xue Zhang, Wei Liu, Zhijing Fu, Zhuoling Chen, Qixin Chen, Yanan Shen, Yukai Jin, Dengfeng Xu, Yin Wang, Xuefeng Qu and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Metabolites, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xue ZhangSchool of Pharmacy, School of Food Science and Engineering, Hangzhou Medical College, Hangzhou 310013, China.
Wei LiuSchool of Pharmacy, School of Food Science and Engineering, Hangzhou Medical College, Hangzhou 310013, China.
Zhijing FuSchool of Pharmacy, School of Food Science and Engineering, Hangzhou Medical College, Hangzhou 310013, China.
Zhuoling ChenSchool of Pharmacy, School of Food Science and Engineering, Hangzhou Medical College, Hangzhou 310013, China.
Qixin ChenSchool of Pharmacy, School of Food Science and Engineering, Hangzhou Medical College, Hangzhou 310013, China.
Yanan ShenSchool of Pharmacy, School of Food Science and Engineering, Hangzhou Medical College, Hangzhou 310013, China.
Yukai JinSchool of Pharmacy, School of Food Science and Engineering, Hangzhou Medical College, Hangzhou 310013, China.
Dengfeng XuSchool of Pharmacy, School of Food Science and Engineering, Hangzhou Medical College, Hangzhou 310013, China.
Yin WangSchool of Pharmacy, School of Food Science and Engineering, Hangzhou Medical College, Hangzhou 310013, China.
Xuefeng QuSchool of Pharmacy, School of Food Science and Engineering, Hangzhou Medical College, Hangzhou 310013, China.
Yangjunna ZhangSchool of Pharmacy, School of Food Science and Engineering, Hangzhou Medical College, Hangzhou 310013, China.

Funding

Zhejiang Provincial Health Commission 2024KY924 and 2023KY708
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

diabetic cardiomyopathymitochondrial quality controlNLRP3 inflammasomepyrroloquinoline quinonetype 2 diabetes

Identifiers

PMID42188049
PMCPMC13209680

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.